Moderna/Merck Personalized mRNA Melanoma Cancer Shot Uses AI-Generated Design
A personalized mRNA melanoma cancer shot developed by Moderna and Merck using an AI generated design has met the primary endpoint in a late-stage phase 3 clinical trial.1 In August, the two pharmaceutical giants reported that, when combined with an existing treatment, the vaccine reduced the risk of melanoma returning or spreading. Cancer experts are enthusiastic […]
Penguins in Australia Given Bird Flu Vaccine Even Though It Can’t Stop Infection and Transmission
Conservation authorities in Australia have launched a mass H5N1 bird flu vaccination campaign among little penguin populations in the states of Victoria and New South Wales.1 In August 2026, Australian authorities confirmed the country’s first case of the H5N1 bird flu in a little penguin, a species that cannot fly, after finding a deceased bird […]
mRNA, Spike Proteins Persist in the Human Body for More Than 3.5 Years After COVID-19 Shots
A newly published case report in Medical Research Archives found that vaccine-derived synthetic mRNA, spike protein and plasmid DNA sequences persisted in the blood and tissue of a 55-year-old man more than three years after his last Pfizer mRNA COVID-19 shot, with some components detected beyond the 3.5-year mark. The case report, published July 1, […]
European Medicines Agency Begins Review of New Lyme Disease Vaccine
European Union (E.U.) officials will begin the study and review process for Pfizer and Valneva’s vaccine targeting Lyme disease, the world’s most common tick-borne illness. There is currently no commercially approved Lyme disease vaccine.1 2 Pfizer, along with French-Swiss pharmaceutical company Valneva say trials have shown 70 percent efficacy in people ages five and older […]
Kindergarten Vaccine Exemptions in U.S. Increase, But Vaccine Uptake Rates Decline Only Slightly
The percentage of children entering kindergarten with exemptions from required vaccines increased during the 2025-2026 school year, according to data from the U.S. Centers for Disease Control and Prevention (CDC) but vaccine uptake rates for children only declined slightly. The national vaccine exemption rate rose to 4.2 percent, up from 3.6 percent last year. The […]
Despite Safety Concerns, FDA Approves Moderna’s mRNA Flu Shot
On Aug. 5, 2026, the U.S. Food and Drug Administration (FDA) approved Moderna’s seasonal flu shot, mFLUSIVA (mRNA-1010), making it the first messenger RNA platform for seasonal influenza in the United States. The decision permits health care providers to use mRNA technology for annual influenza vaccination in eligible age groups.1 FDA regulators approved mFLUSIVA to […]